Importantly, the current evidence supporting this approach is largely indirect and derived from studies conducted in patients with established PsO and metabolic comorbidities, rather than in well-characterized early PsA cohorts.An additional and largely underexplored aspect concerns the safety of combining GLP-1RAs with bDMARDs
With a training stimulus, even moderate protein intake preserves most of the muscle that matters, because the mechanical signal tells the body the tissue is necessary and the protein supplies the amino acids to rebuild it
Clear timelines interpreted faster, clinicians resolved flagged lab changes more quickly when patients provided concise dose and symptom logs during the first three months, while fragmented notes and screenshots prolonged visits and increased anxiety
I think the cost-benefit analysis will come out that there is a net gain because of the prevention of all the chronic diseases in the hospital and care costs associated with that. However, Small also urged caution for those thinking of going on the drugs
For most people on GLP-1 medications who are strength training consistently, the story is encouraging: fat goes down, muscle holds or improves
